PapersPMID:31828538
Effects of carnitine supplementation on liver aminotransferase enzymes: A systematic review and meta-analysis of randomized controlled clinical trials.
- findings
- 2
- compound
- 1
- endpoints
- 2
(R)-carnitine- Study, every finding
- meta-analysis
- Population, every finding
- Participants of 17 randomized controlled trials, pooled analysis
What moved
How to read these marks →“Random effects model meta-analysis showed that carnitine supplementation led to reduction in serum ALT (weighted mean difference [WMD] - 10.25 IU/L; 95% CI = - 15.73, - 4.77; p < 0.001) and AST levels (WMD - 7.85 IU/L; 95% CI = - 11.85, - 3.86; p < 0.001).”
- Decreases aspartate aminotransferase
very limitedreplicated ×2
- Effect
- −7.85 mean difference, 95% CI −11.85 to −3.86
- Decreases alanine aminotransferase
very limitedreplicated ×3
- Effect
- −10.25 mean difference, 95% CI −15.73 to −4.77
Study record
- Design
- meta-analysis
- Species
- human
- Population
- participants in 17 randomized controlled trials of carnitine supplementation
- Participants
- not reported
- Comparator
- not stated in the paper
- Duration
- not reported
- Endpoints measured
- 7